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The protective effect of Lactobacillus acidophilus and Lactobacillus casei, isolated from fresh cow milk, 
was studied in vivo. Toxicological data of rat serum revealed that the Lactobacillus isolates had liver 
improvement functions. Serum alanine aminotransferase (ALT) activities of the rats dosed with 
Lactobacillus isolates alone were lower (15.50 and 18.27 iu/l) than the control. There was a reduction in 
the count of enterobacteria in rats dosed with L. casei after 3 days of feeding trials. Protection of the 
gastrointestinal tract (GIT) by these isolates was also observed. Histopathological data confirmed 
partial protection of the GIT in rats dosed with Lactobacillus isolates and simultaneously infected with 
Escherichia coli. L. casei was generally observed to have a better effect than L. acidophilus in terms of 
liver function improvement, anticholesterolaemic effect, and reduction of enterobacteria in the GIT.    
 





Gastrointestinal disorders are caused by various factors 
including antibiotic administration (Van der Waaij et al., 
1982), or as a result of infectious agents such as 
toxigenic Escherichia coli, Salmonella enteritidis, 
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Innovative approaches have been tried as alternative to 
antibiotics in treating gastrointestinal diseases and these 
include using live biotherapeutic agents such as yeast 
(Saccharomyces spp.) and bacterial isolates 
(Lactobacillus spp.) or faecal enemals (Fuller, 1992). 
Lactobacilli are important for the maintenance of the 
intestinal microbial ecosystem (Sandine, 1979). 
Colonisation of the gut with Lactobacilli starts within the 






this group of bacteria in the gut is considered to have 
several potential benefits such as growth enhancement of 
farm animals (Baird, 1977), protection from pathogens 
(Casas and Dobrogosz, 2000), alleviation of lactose 
intolerance (Jiang et al., 1996), relief of constipation 
(Walker and Duffy, 1998), anticholesterolaemic effect 
(Bertazzoni et al., 2001) and immunostimulation (Aattouri 
et al., 2001). Lactobacilli exert their protective or 
therapeutic effect through production of antimicrobial 
compounds (Dodd and Gasson, 1994), reduction of gut 
pH by stimulating the lactic acid producing microflora 
(Langhendries, 1995), competition for binding of receptor 
sites that pathogens occupy (Kailasapathy and Chin, 
2000), stimulation of immunomodulatory cells (Rolfe, 
2000) and competition with pathogens for available 
nutrients (Rolfe, 2000). 
Walker and Duffy (1998) suggested that current 
perspectives on biotechnological applications of probiotic 
products require further in vitro and in vivo investigation 
to evaluate the safety of using wild type organisms or 
those obtained by genetic engineering. The present study 
is therefore aimed at understanding the protective effect 
of L. acidophilus and L. casei from fresh cow milk, and 
their ability to reduce the toxicological and pathological 
consequences associated with enterotoxigenic E. coli 
used to experimentally infect rats. 
 
 




L. acidophilus and L. casei were isolated from fresh cow milk on 
deMann Rogosa and Sharpe (MRS) agar. The isolates were 
characterised using colonial, morphological, and biochemical 
methods. Preliminary studies show that these two isolates are 
capable of inhibiting food spoilage and pathogenic bacteria. These 
Lactobacillus species were also found to adhere to the ileal 
epithelial ell (IEC) of albino rat. The isolates were cultured in MRS 
broth and incubated at 370C for 2 days to obtain large cell 
concentration of approximately 1010 cfu/g. The cells were washed, 
suspended in rehydrated skim milk (10% w/v), lyophilised, and 
stored at –200C until use (Fujiwara et al., 2001). The concentration 
of the viable cells was determined by serial dilution techniques 
(Taylor, 1962).  
 
 
In vivo feeding 
 
Twenty four albino rat (Wistar strain) aged 5 – 6 weeks were 
obtained from Department of Physiology, University of Ibadan. The 
rats were fed on basal diet purchased from Bendel feed, Edo State, 
Nigeria for 1 week ad libitum before the treatment. They were 
randomly assigned to 6 treatment groups designated as C, SA, SC, 
CA, CC and CT. Each was made up of 4 rats per group. Lyophilised 
Lactobacillus cells were reconstituted by dissolving 1 g in 10 ml of 
sterile water (approximately 1010 cfu/ml). Group C was kept on the 
basal diet alone (control). Groups SA and SC were fed on the basal 
diet and were also dosed with 0.3 ml of L. acidophilus and L. casei, 
respectively. Groups CA and CC were fed the basal diet, dosed 
with 0.3 ml of L. acidophilus and L. casei, respectively, and infected  




with 0.3 ml of 105 cfu/ml enterotoxigenic E. coli obtained from 
culture collection of the Department of Microbiology, Obafemi 
Awolowo University, Ile-Ife, Nigeria. Group CT was fed on basal diet 
and also infected with 0.3 ml of 105 cfu/ml of E. coli. The treatment 
above was repeated the second day. A post ingestion period of 18 
days was observed after the administration of the cultures. The rats 
were killed by cervical dislocation and the blood samples of the rats 





Reflotron M06.02<06.00 (Boehringer Mannheim company, 
Germany) was used for the analyses of some major serum 
biochemical markers that can reveal the effects of the administered 
culture on the rat. The biomarkers assayed for were aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), alkaline 
phophatase (ALP) and total cholesterol of the serum. Standardised 
amount of the sample were automatically pipetted and applied on 
the test strip. The strip was inserted into the test chamber and result 
was displayed after some seconds on the computer monitor. The 
tests were carried out at 250C. 
 
 
Bacterial count in faeces of rats 
 
Freshly voided faecal materials were collected and pooled from 
each rat (1 g/rat) at days zero and 3. This was done to confirm if the 
Lactobacillus species were able to survive the stress within the 
gastrointestinal tract (GIT). The faeces were homogenised in 
normal saline and serially diluted. The diluted homogenates (0.1 ml) 
were plated on MRS agar for the enumeration of lactobacilli and on 
MacConkey agar for the enumeration of enterobacteria, especially 
E. coli. The plates were incubated at 370C for 24 h and colony 





The small intestine of the rats were removed. The organs were 
fixed in 10% formalin, dehydrated in increasing percentages of 
alcohol, cleared in xylene for 2 h for embedding. The embedded 
organs were sectioned using microtome and stained with 





The data gathered from toxicological assay and faecal flora assay 
were processed using one way Analysis of Variance (ANOVA), 
SPSS 10.0. The level of significance was set at P < 0.05. Means 
were compared by Duncan T- tests. 
 
 
RESULTS AND DISCUSSION 
 
The aspartate aminotransferase (AST) activity of rats 
treated with L. casei and challenged with E. coli (CC) was 
highest and significantly different (P < 0.05) from the 
control (C) (Table 1). AST is an enzyme that increases in 
activity in diseases such as severe bacterial infections, 
malaria, pneumonia, pulmonary infarcts, and tumours of 
organs such as heart and muscle (Cheesbrough, 1991). 
Lactobacilli can translocate (Berg,  1983)  and  survive  in  
 




                       Table 1.  Serum biochemical markers in rats after in vivo feeding trials. 
 
Group AST (iu/l) ALT (iu/l) ALP (iu/l) Cholesterol (mg/dl) 
    C 
    SA 
    SC 
    CA 
    CC 

























Values are means ± SD of 4 replicates per group. *Values along column are significantly different (P < 0.05) from the 
control (C). C: rats placed on basal feed alone. SA: rats placed on basal feed and dosed with L. acidophilus. SC: rats 
placed on basal feed and dosed with L. casei. CA: rats placed on basal feed, dosed with L. acidophilus and challenged 
with E. coli. CC: rats placed on basal feed, dosed with L. casei and challenged with E. coli. CT: rats placed on basal 
diet and challenged with E. coli.   
 
 
the spleen, liver, and lungs (Bloksma, 1981). In the 
course of their translocation, they can cause cellular 
injury that may increase AST level in the serum. This may 
account for increase in AST observed for rats in groups 
SA and SC when compared with the control (C). The 
higher AST level observed in groups CA and CC may be 
due to the combine activities of Lactobacillus and E. coli 
in the GIT. In their study, Silva et al. (1999) reported that 
to obtain protective effect in animals, treatment with a 
probiotic agent had to be initiated 10 days before 
challenge with a pathogen. But, in this report orogastric 
dosing with Lactobacillus and challenge with E. coli was 
simultaneous. Moreover, the Alanine aminotransferase 
(ALT) activities of the serum in the rats also reveal that 
groups CA and CC dosed with Lactobacillus and 
simultaneously challenged with E. coli, were significantly 
higher (P < 0.05) than the control (C). Alanine 
aminotransferase (ALT) is principally found in the liver 
and is regarded as being more specific than AST for 
detecting liver cell damage (Johnston, 1991; 
Cheesbrough, 1991). The implication of this result is that, 
there is a pronounced toxicological effect in rats of 
groups CT, CA, and CC. The lower ALT values in rats 
treated with Lactobacillus alone (SA and SC) compared 
to the control indicate liver function improvement brought 
about by the Lactobacillus. Hepatocytes play a major role 
in absorbing and metabolising many toxic chemicals (Eka 
et al., 1994). They are therefore liable to injury by various 
chemicals, including food. 
The ALP activities of rats treated with Lactobacillus and 
E. coli (CT, CA, and CC) were also significantly higher (P 
< 0.05) than those recorded in those treated with 
Lactobacillus only (SA and SC). A rise in ALP activities 
has been linked with an increased osteoblastic activity 
(Baron et al. 1994) and lack of bile flow (cholestasis). 
Only a slight anticholesterolaemic effect was also 
observed in rats treated with Lactobacillus. Lactobacilli 
had been found to have direct effect on cholesterol levels 
by assimilation  and  removal  from  the  growth  medium.  
 
 
Figure 1. Histopathological section of small intestine of rat dosed 
with L. acidophilus isolated from fresh cow milk. Arrow shows intact 
intestinal villus pattern (X 100). 
 
 
This had been demonstrated in pigs (Gilliland et al., 
1985) and in rats (Bertazzoni et al., 2001). Serum ALT 
and ALP levels had been reported to increase with 
increase in serum cholesterol (Johnston, 1999).  
The result of the histopathological analysis confirmed 
the protective effect of the lactobacillus alone. The 
protection of the GIT was observed in rats treated with 
Lactobacillus (SA and SC), where the villus patterns of 
the small intestine of the rats were well preserved (Figure 
1). In rats treated with Lactobacillus and E. coli (CA and 
CC), there was partial protection of the villus pattern 
(Figure 2) while the intestinal villus pattern of group 
treated with E. coli only (CT) was markedly eroded 
(Figure 3). The mucus is as a result of wearing off of the 
intestinal epithelial cells. 
The ability of the isolates to protect the GIT against 
pathogens can be confirmed by monitoring the count of 
enterobacteria, especially E. coli and beneficial bacteria 
e.g. Lactobacilli, in rat faeces (Mitsuoka, 1992). There 
was  an  increase  in  faecal   Lactobacilli   count   in   rats  
 




                               Table 2. Total count of faecal bacteria during feeding trials. 
 
Enterobacteria count Lactobacilli count  
Group 
Day 0 Day 3 Day 0 Day 3 
    C 
    SA 
    SC 
    CA 
    CC 






























Figure 2. Histopathological section of the small intestine of rat 
dosed with L. acidophilus and challenged with E. coli. Arrow shows 






Figure 3. Histopathological section of the small intestine of rat 
challenged with E. coli. Arrow shows area where the intestinal villus 
pattern was markedly eroded (X 200). 
 
 
treated with Lactobacilli (Table 2). A slight decrease in 
enterobacteria count was also observed in most of the 
rats. There was increase in the enterobacteria and 
Lactobacilli count from day zero (0) to day 3 in both 
controls (C and CT). In a similar study, Chang et al. 
(2001) reported an increase in the Lactobacilli count in 
faeces of rat that was fed basal diet devoid of probiotic 
agent. The high Lactobacilli count in groups treated with 
Lactobacilli and E. coli (CA and CC) may be responsible 
for the partial protection of the GIT of rats in these 
groups.   
Earlier report showed that a selected probiotic strain L. 
reuteri and L. acidophilus showed increasing effect on 
numbers of enterobacteria in piglets (Ratcliffe et al. 
1986). The ability of the lactobacilli to produce toxic 
metabolites such as lactic acid, hydrogen peroxide (H202) 
and bacteriocin has been suggested as being responsible 
for their ability to inhibit other bacteria (Juven et al. 1992). 
Other factors such as host immunomodulation (Hatcher 
and Lambrecht, 1983) also play a prominent role. The 
report presented here showed that L. casei has a better 
probiotic effect than L. acidophilus in terms of liver 
function improvement, anticholesterolaemic property, and 
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